Stem cell differentiation, plasticity and regenerative mechanisms in the cholinergic system : implications for Alzheimer’s disease
Author: Nilbratt, Mats
Date: 2008-03-17
Location: Hörsalen, plan 4, Novum forskningspark, Hälsovägen 7, Huddinge
Time: 10.00
Department: Institutionen för neurobiologi, vårdvetenskap och samhälle / Department of Neurobiology, Care Sciences and Society
View/ Open:
thesis.pdf (1.630Mb)
Abstract
Stem cells are immature cells with self-renewal capacity. They are able
to differentiate into multiple lineages that may serve as a source of
expandable cells for various applications. To generate cell populations
of a specific lineage, it is crucial to understand the regulatory role of
local environmental cues, intrinsic factors and signaling pathways that
control their cellular phenotype.
The main purposes of the present work were to examine factors that act as induction signals and modulate neuronal differentiation and plasticity, especially as regards the cholinergic phenotype, and also to examine possible interactive mechanisms between neurotrophic factors, cholinergic receptors and the amyloid precursor protein (APP) in stem cell biology.
Human embryonic stem (hES) cells from six different lines were used to evaluate defined conditions for neural differentiation in adherent and suspension culture systems. In serum-free and feeder-free cultures, a dynamic transition into neuroepithelial and radial glial cells was observed, and these neurogenic cells finally gave rise to neurons. For these lines of hES cells, a similar progression of neural differentiation occurred, suggesting that hES cells may serve as an important model system to study early neuronal developmental processes.
Alzheimer’s disease (AD) is associated with amyloid plaques, neurofibrillary tangles, and a marked loss of basal forebrain cholinergic neurons and neuronal nicotinic acetylcholine receptors (nAChRs) expressed on these neurons.
Examination of the subregional lineage of hES cell-derived neurons revealed expression of transcription factors specifying telencephalic neuronal identity. Moreover, these cells also expressed α3, α4 and α7 nAChR subunits and M1, M2 and M3 muscarinic receptor subtypes. Upon stimulation with neurotrophic factors, including brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT3), ciliary neurotrophic factor (CNTF) and nerve growth factor (NGF), the expression of the cholinergic enzyme choline acetyltransferase was increased, which was also observed in the septal SN56 cell line following treatment with retinoic acid (RA). Additionally, RA treatment upregulated the expression of α3 but reduced the level of α4 nAChR subunits in SN56 cells. Stimulation with neurotrophic factors also upregulated the α3 nAChR subunit and M3 mAChR subtype in hES cell-derived neurons, suggesting differential regulation of various AChR subtypes in both septal SN56 and hES cell-derived neurons. The expression of functional cholinergic receptors was demonstrated by a calcium increase evoked by acetylcholine (ACh), and the proportion of responding cells was dependent on the concentration of ACh, which suggests that multiple subtypes of cholinergic receptors were expressed in hES cell-derived neurons.
An understanding of stem cell biology during pathological conditions is crucial for future stem cell-based therapeutical approaches. As disturbances in the microenvironment due to brain injury or pathology could affect the microenvironmental equilibrium, the cells may be exposed to cues that are different from those in their normal conditions that may ultimately affect their phenotype and function. To study this, APP23 transgenic mice were treated with the novel drug (+)-phenserine, which reduced the expression of APP. This treatment also increased the neuronal differentiation of transplanted human neural precursor cells (NPCs), whereas astrocytic differentiation was reduced, indicating a role for APP as cell fate determinant of NPCs in vivo. These findings suggest that a combined treatment and transplantation approach may be necessary in order to further examine the potential of transplantable cells for developing future cell-based treatment strategies of neurodegenerative diseases, including AD.
In conclusion, the findings in the present study demonstrate that hES cells may serve as an important model system to study cellular mechanisms in early human neural development. Exploring the mechanisms of action of RA, BDNF, NT3, CNTF and NGF, which act as inductive signals for differentiation processes and plasticity of hES cells, NPCs and cholinergic neurons, may also lead to the development of novel strategies for future therapeutic interventions in AD.
The main purposes of the present work were to examine factors that act as induction signals and modulate neuronal differentiation and plasticity, especially as regards the cholinergic phenotype, and also to examine possible interactive mechanisms between neurotrophic factors, cholinergic receptors and the amyloid precursor protein (APP) in stem cell biology.
Human embryonic stem (hES) cells from six different lines were used to evaluate defined conditions for neural differentiation in adherent and suspension culture systems. In serum-free and feeder-free cultures, a dynamic transition into neuroepithelial and radial glial cells was observed, and these neurogenic cells finally gave rise to neurons. For these lines of hES cells, a similar progression of neural differentiation occurred, suggesting that hES cells may serve as an important model system to study early neuronal developmental processes.
Alzheimer’s disease (AD) is associated with amyloid plaques, neurofibrillary tangles, and a marked loss of basal forebrain cholinergic neurons and neuronal nicotinic acetylcholine receptors (nAChRs) expressed on these neurons.
Examination of the subregional lineage of hES cell-derived neurons revealed expression of transcription factors specifying telencephalic neuronal identity. Moreover, these cells also expressed α3, α4 and α7 nAChR subunits and M1, M2 and M3 muscarinic receptor subtypes. Upon stimulation with neurotrophic factors, including brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT3), ciliary neurotrophic factor (CNTF) and nerve growth factor (NGF), the expression of the cholinergic enzyme choline acetyltransferase was increased, which was also observed in the septal SN56 cell line following treatment with retinoic acid (RA). Additionally, RA treatment upregulated the expression of α3 but reduced the level of α4 nAChR subunits in SN56 cells. Stimulation with neurotrophic factors also upregulated the α3 nAChR subunit and M3 mAChR subtype in hES cell-derived neurons, suggesting differential regulation of various AChR subtypes in both septal SN56 and hES cell-derived neurons. The expression of functional cholinergic receptors was demonstrated by a calcium increase evoked by acetylcholine (ACh), and the proportion of responding cells was dependent on the concentration of ACh, which suggests that multiple subtypes of cholinergic receptors were expressed in hES cell-derived neurons.
An understanding of stem cell biology during pathological conditions is crucial for future stem cell-based therapeutical approaches. As disturbances in the microenvironment due to brain injury or pathology could affect the microenvironmental equilibrium, the cells may be exposed to cues that are different from those in their normal conditions that may ultimately affect their phenotype and function. To study this, APP23 transgenic mice were treated with the novel drug (+)-phenserine, which reduced the expression of APP. This treatment also increased the neuronal differentiation of transplanted human neural precursor cells (NPCs), whereas astrocytic differentiation was reduced, indicating a role for APP as cell fate determinant of NPCs in vivo. These findings suggest that a combined treatment and transplantation approach may be necessary in order to further examine the potential of transplantable cells for developing future cell-based treatment strategies of neurodegenerative diseases, including AD.
In conclusion, the findings in the present study demonstrate that hES cells may serve as an important model system to study cellular mechanisms in early human neural development. Exploring the mechanisms of action of RA, BDNF, NT3, CNTF and NGF, which act as inductive signals for differentiation processes and plasticity of hES cells, NPCs and cholinergic neurons, may also lead to the development of novel strategies for future therapeutic interventions in AD.
List of papers:
I. Nilbratt M, Friberg L, Mousavi M, Marutle A, Nordberg A (2007). "Retinoic acid and nerve growth factor induce differential regulation of nicotinic acetylcholine receptor subunit expression in SN56 cells." J Neurosci Res 85(3): 504-14
Pubmed
II. Nat R, Nilbratt M, Narkilahti S, Winblad B, Hovatta O, Nordberg A (2007). "Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures." Glia 55(4): 385-99
Pubmed
III. Nilbratt M, Porras O, Marutle A, Hovatta O, Nordberg A (2007). "Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons." (Submitted)
IV. Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K (2007). "Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine." Proc Natl Acad Sci U S A 104(30): 12506-11. Epub 2007 Jul 17
Pubmed
I. Nilbratt M, Friberg L, Mousavi M, Marutle A, Nordberg A (2007). "Retinoic acid and nerve growth factor induce differential regulation of nicotinic acetylcholine receptor subunit expression in SN56 cells." J Neurosci Res 85(3): 504-14
Pubmed
II. Nat R, Nilbratt M, Narkilahti S, Winblad B, Hovatta O, Nordberg A (2007). "Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures." Glia 55(4): 385-99
Pubmed
III. Nilbratt M, Porras O, Marutle A, Hovatta O, Nordberg A (2007). "Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons." (Submitted)
IV. Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K (2007). "Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine." Proc Natl Acad Sci U S A 104(30): 12506-11. Epub 2007 Jul 17
Pubmed
Issue date: 2008-02-25
Rights:
Publication year: 2008
ISBN: 978-91-7357-541-6
Statistics
Total Visits
Views | |
---|---|
Stem ...(legacy) | 966 |
Stem ... | 108 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Stem ... | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
File Visits
Views | |
---|---|
thesis.pdf(legacy) | 412 |
thesis.pdf | 125 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 391 |
Sweden | 70 |
China | 69 |
Germany | 68 |
South Korea | 27 |
Russia | 17 |
Finland | 14 |
Denmark | 10 |
France | 9 |
Japan | 9 |
Top cities views
Views | |
---|---|
Sunnyvale | 50 |
Romeo | 40 |
Beijing | 32 |
Kiez | 29 |
Seoul | 26 |
Stockholm | 13 |
Nürnberg | 11 |
Ballerup | 10 |
Dublin | 8 |
Helsinki | 8 |